More articles from Drug Discovery and Translational Medicine

You have access
Identification of glucose transport modulators in vitro and method for their deep learning neural network behavioral evaluation in Glut1 deficient mice
Gauri Kathote, Qian Ma, Gustavo Angulo, Hong Chen, Vikram Jakkamsetti, Aksharkumar Dobariya, Levi B. Good, Bruce Posner, Jason Y. Park and Juan M. Pascual

Journal of Pharmacology and Experimental Therapeutics January 12, 2023, JPET-AR-2022-001428; DOI: https://doi.org/10.1124/jpet.122.001428
Open Access
Translational PK/PD Modeling of Tumor Growth Inhibition and Target Inhibition to Support Dose Range Selection of the LMP7 Inhibitor M3258 in Relapsed/Refractory Multiple Myeloma
Floriane Lignet, Christina Esdar, Gina Walter-Bausch, Manja Friese-Hamim, Sofia Stinchi, Elise Drouin, Samer El Bawab, Andreas D. Becker, Claude Gimmi, Michael P. Sanderson and Felix Rohdich

Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 163-172; DOI: https://doi.org/10.1124/jpet.122.001355
You have access
The Novel, Clinical Stage Soluble Guanylate Cyclase Activator BI 685509 Protects from Disease Progression in Models of Renal Injury and Disease
Glenn A. Reinhart, Paul C. Harrison, Kathleen Lincoln, Hongxing Chen, Peng Sun, Jon Hill, Hu Sheng Qian, Mark McHugh, Holly Clifford, Khing Jow Ng, Hong Wang, Danielle Fowler, Kristina K. Gueneva-Boucheva, Todd Bosanac, Diane Wong, Ryan M. Fryer, Chris Sarko, Carine M Boustany-Kari and Steven S. Pullen

Journal of Pharmacology and Experimental Therapeutics December 6, 2022, JPET-AR-2022-001423; DOI: https://doi.org/10.1124/jpet.122.001423
You have access
The effects of dual GLP-1/GCG receptor agonists with different receptor selectivity in mouse models of obesity and NASH
Ashref Kayed, Simone Anna Melander, Suheb Khan, Kim Vietz Andreassen, Morten Asser Karsdal and Kim Henriksen

Journal of Pharmacology and Experimental Therapeutics November 23, 2022, JPET-AR-2022-001440; DOI: https://doi.org/10.1124/jpet.122.001440
You have access
Pharmacodynamic and Antitumor Activity of BI 836880, a Dual VEGF and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 Inhibition
Irmgard Hofmann, Anke Baum, Marco H. Hofmann, Francesca Trapani, Claudia Reichel-Voda, Diane Ehrensperger, Martin Aichinger, Florian Ebner, Nicole Budano, Norbert Schweifer, Martina Sykora, Erik Depla, Joachim Boucneau, Andreas Gschwind, Norbert Kraut, Frank Hilberg and Klaus-Peter Künkele

Journal of Pharmacology and Experimental Therapeutics October 14, 2022, JPET-AR-2022-001255; DOI: https://doi.org/10.1124/jpet.122.001255
You have access
A Novel Truncated Liver Enriched Antimicrobial Peptide-2 Palmitoylated at its N-Terminal Antagonizes Effects of Ghrelin
Lucie Holá, Blanka Železná, Alena Karnošová, Jaroslav Kuneš, Jean-Alain Fehrentz, Séverine Denoyelle, Sonia Cantel, Miroslava Blechová, David Sýkora, Aneta Myšková and Lenka Maletínská

Journal of Pharmacology and Experimental Therapeutics November 2022, 383 (2) 129-136; DOI: https://doi.org/10.1124/jpet.122.001322
Open Access
Mitochondrial Dysfunction and Pharmacodynamics of Mitofusin Activation in Murine Charcot-Marie-Tooth Disease Type 2A
Antonietta Franco, Xiawei Dang, Lihong Zhang, Perry B. Molinoff and Gerald W. Dorn

Journal of Pharmacology and Experimental Therapeutics November 2022, 383 (2) 137-148; DOI: https://doi.org/10.1124/jpet.122.001332
You have access
Is Diminazene an Angiotensin-Converting Enzyme 2 (ACE2) Activator? Experimental Evidence and Implications
Shiva Hadi Esfahani, Srinidhi Jayaraman and Vardan T. Karamyan

Journal of Pharmacology and Experimental Therapeutics November 2022, 383 (2) 149-156; DOI: https://doi.org/10.1124/jpet.122.001339
Open Access
Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia-Inducible Factor Prolyl-4-Hydroxylase Inhibitor, for the Potential Treatment of Renal Anemia
Anna Zuk, Zhihai Si, Sally Loi, Santhosh Bommegowda, Debie Hoivik, Sanjay Danthi, Gyongyi Molnar, Vilmos Csizmadia and Michael Rabinowitz

Journal of Pharmacology and Experimental Therapeutics October 2022, 383 (1) 11-24; DOI: https://doi.org/10.1124/jpet.122.001126
You have access
Effect of Novel Biotherapeutic Elevating Angiopoietin 1 on Progression of Diabetic Nephropathy in Diabetic/Obese Mice
Peng Sun, Christina S. Bartlett, Chao Zheng, Tammy Bigwarfe, Joshuaine M. Grant, Margit MacDougall, Valentina Berger, Steven Kerr, Hu Sheng Qian, Mark McHugh, Hongxing Chen, Xiaomei Zhang, Miranda L. Carpenter, Heather N. Robinson, John Miglietta, Thorsten Lamla and Ryan M. Fryer

Journal of Pharmacology and Experimental Therapeutics September 2022, 382 (3) 266-276; DOI: https://doi.org/10.1124/jpet.121.001067

Main menu

User menu

Search

More articles from Drug Discovery and Translational Medicine

Pages

Navigate

More Information

ASPET's Other Journals